The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(5-(3,3-difluorocyclobutyl)-6-methoxypyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione ID: ALA4790960
PubChem CID: 149128190
Max Phase: Preclinical
Molecular Formula: C13H12F2N4O3
Molecular Weight: 310.26
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1nnc(-c2c[nH]c(=O)[nH]c2=O)cc1C1CC(F)(F)C1
Standard InChI: InChI=1S/C13H12F2N4O3/c1-22-11-7(6-3-13(14,15)4-6)2-9(18-19-11)8-5-16-12(21)17-10(8)20/h2,5-6H,3-4H2,1H3,(H2,16,17,20,21)
Standard InChI Key: RBOSEAYBAPUFLX-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
40.2448 -7.3092 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
40.6617 -8.0264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0743 -7.3067 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
37.7847 -11.6540 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.7847 -12.4796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4972 -12.8882 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.2098 -12.4796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2098 -11.6540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4972 -11.2370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9227 -11.2442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6364 -11.6613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.3504 -11.2541 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.3571 -10.4282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6434 -10.0111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9232 -10.4199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4972 -10.4115 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.0703 -12.8934 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.0748 -10.0202 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.6515 -9.1884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2384 -8.6164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0750 -8.6050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.7870 -10.4378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
4 9 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
10 11 1 0
10 15 2 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
8 10 1 0
9 16 2 0
5 17 2 0
13 18 1 0
19 14 1 0
19 20 1 0
20 2 1 0
2 21 1 0
21 19 1 0
18 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 310.26Molecular Weight (Monoisotopic): 310.0877AlogP: 1.04#Rotatable Bonds: 3Polar Surface Area: 100.73Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.80CX Basic pKa: 0.34CX LogP: 0.15CX LogD: 0.13Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.88Np Likeness Score: -0.54
References 1. Jeffrey JL,Lawson KV,Powers JP. (2020) Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39., 63 (22): [PMID:32786396 ] [10.1021/acs.jmedchem.0c01044 ]